Safety and efficacy of ablative fractional CO2 laser thrapy for external genital and the vagina in women with lower urinary tract symptom

Safety and efficacy of ablative fractional CO2 laser thrapy for external genital and the vagina in women with lower urinary tract symptom - AFLT study for LUTS

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027741

Enrollment

Registered

2017-06-13

Start date

2017-06-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Over active bladder syndrome and stress urinary incontinence

Interventions

ablative fractional laser therapy by Smarttxide2

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: OAB and/or SUI patients who want to evade operation or medecal treatment

Exclusion criteria

Exclusion criteria: 1) heart disease 2) severely lung disease 3) neurogenic bladder syndrome 4) pelvic organ prolapse (more than 3) 5) pragnancy

Design outcomes

Primary

Measure	Time frame
Effect of AFLT at pre, 3 months, half a year and one year by urinary diary	—

Secondary

Measure	Time frame
Effect of AFLT at pre, 3 months, half a year and one year by questionnaire and objective evaluation	—

Countries

Japan

Contacts

Public ContactNoriko Ninomiya

Women Clinic LUNA SHINSAIBASHI Urology

ninomiya5829@yahoo.co.jp0662517505

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026